Tenneco, VeriFone, New Gold, Humana Biggest Stock Price Percentage Losers April 30th
Tenneco Inc. (NYSE:TEN): Reports Q1 revenue $1.91B versus consensus $1.89B. The shares closed at $30.83, down $5.26, or 14.57%. They have traded in a 52-week range of $22.47 to $46.80.
VeriFone Systems Inc (NYSE:PAY): VeriFone Systems issued the following statement regarding a report on organic growth calculations that was disseminated this morning from Deutsche Bank. “VeriFone uses a methodology of calculating organic growth prescribed by the vast majority of investors and Wall Street analysts: excluding revenue of all acquired companies, large and small, until 12 months after acquisition. Deutsche Bank is choosing to include in its calculation the revenue of acquired companies as if VeriFone had owned them for the entire current and year-ago period. We believe this does not reflect the true organic results of VeriFone’s business and we reaffirm our expectations for 10-15% organic growth rates for fiscal year 2012 and long-term.” The shares closed at $47.64, down $6.8, or 12.49%. They have traded in a 52-week range of $30.25 to $55.89.
New Gold Inc. (NYSEAMEX:NGD): New Gold announced that the Chilean Supreme Court has temporarily suspended the approval of the environmental permit for the El Morro Project. The El Morro Project is a joint venture between New Gold and Goldcorp (NYSE:GG), where New Gold is a 30% partner and Goldcorp is the 70 percent partner and the project developer and operator. The environmental permit was originally approved on March 14, 2011. The shares closed at $9.10, down $0.92, or 9.18%. They have traded in a 52-week range of $8.69 to $14.15.
Hologic, Inc. (NASDAQ:HOLX): Leerink believes shares of Hologic (NASDAQ:HOLX) could remain under pressure in the near-term as investors digest the company’s slightly weaker than expected Q2 breast health sales and the Gen-Probe (NASDAQ:GPRO) acquisition. The firm has an Outperform rating on the stock. The shares closed at $19.12, down $2.11, or 9.94%. They have traded in a 52-week range of $13.90 to $23.24.
Humana Inc. (NYSE:HUM): Sees FY12 Retail segment revenue $24.5B-$25B; Sees FY12 Employer Group segment revenue $10.5B-$11B; Sees FY12 Health and Well-being Services segment revenue $13.25B-$13.75B.
The shares closed at $80.68, down $7.14, or 8.13%. They have traded in a 52-week range of $65.20 to $96.46.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.